Announcements Trials
Browse Landscape

Phase

Phase 2 5

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5

Conditions

Endometrial Neoplasms 10Uterine Cervical Neoplasms 5Ovarian Neoplasms 5Neoplasm Metastasis 5Pancreatic Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Triple Negative Breast Neoplasms 2Rectal Neoplasms 2Lung Neoplasms 2Locally Advanced Rectal Cancer (LARC) 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Carcinoma, Neuroendocrine 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Recurrence 1Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) 1Penile Neoplasms 1Pathologic Complete Response 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Mouth Neoplasms 1

Interventions

Cisplatin 101Radiotherapy 53Brachytherapy 41Paclitaxel 37Carboplatin 36Surveys and Questionnaires 28Blood Specimen Collection 20pembrolizumab 19Radiation 17Magnetic Resonance Spectroscopy 17Drug Therapy 17Colposcopy 16Bevacizumab 15Methods 14Early Intervention, Educational 12toripalimab 11Topotecan 11Radiotherapy, Intensity-Modulated 11Papanicolaou Test 11Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 11Chemoradiotherapy 11Biopsy 11camrelizumab 10Mass Screening 10Gemcitabine 10Patient Navigation 9Papillomavirus Vaccines 9Nivolumab 9Fluorodeoxyglucose F18 9Educational Status 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Uterine Cervical Neoplasms × dostarlimab × Clear all
NCT06023862 2026-05-06

DOVE

Yonsei University

Phase 2 Recruiting
198 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT04068753 2026-02-10

STAR

University of Oklahoma

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07336147 2026-01-14

Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical Carcinoma

Chang Gung Memorial Hospital

Phase 2 Recruiting
45 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT06238635 2026-01-13

Dostarlimab and Cobolimab in Advanced Cervical Cancer

Beth Israel Deaconess Medical Center

Phase 2 Active not recruiting
66 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03833479 2025-05-21

ATOMICC

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Active not recruiting
134 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡